PhRMA President Alan Holmer Expected To Announce Resignation
Alan Holmer, president and CEO of the Pharmaceutical Research and Manufacturers of America, on Friday is expected to announce his resignation, The Hill reports. Holmer, who has served as the pharmaceutical industry lobbying group's president since 1996, will retire after a successor is chosen later this year, according to a PhRMA draft press release, The Hill reports. It is unknown who will replace Holmer, but retiring Sen. John Breaux's (D-La.) name "surfaced days before Holmer's resignation," The Hill reports. However, a Breaux spokesperson last week said that she had not heard that PhRMA was interested in hiring the senator, according to The Hill (Cusack/Snyder, The Hill, 1/15). Holmer said in the draft press release, "I love my job, and I love this industry. ... But there's a time to move on, and later this year will be that time for me." Robert Essner, chair of the PhRMA board of directors and chair and CEO of Wyeth, said that Holmer "can take great pride" in "achieving enactment of a good Medicare drug benefit to provide insurance coverage for seniors and the disabled, benefiting patients who need medicines most" (PhRMA draft release, 1/15).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.